Ironwood Pharmaceuticals (IRWD) Operating Expenses (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Operating Expenses of $33.9 million for Q1 2026, down 17.04% sequentially from $40.9 million in Q4 2025, and down 51.7% YoY from $70.3 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Operating Expenses (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Operating Expenses for 17 years, with the latest figure at $33.9 million in Q1 2026.
- Quarterly Operating Expenses fell 51.7% year-over-year to $33.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.3 million (down 39.05% YoY) and the FY2025 annual result came in at $197.6 million, down 23.48% from the prior year.
- Operating Expenses fell to $33.9 million in Q1 2026 per IRWD's latest filing, from $40.9 million in the prior quarter.
- Over five years, Operating Expenses peaked at $1.2 billion in Q2 2023 and troughed at $33.9 million in Q1 2026.
- A 5-year average of $119.9 million and a median of $46.6 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 2763.48% in 2023, then tumbled 94.17% in 2024.
- Over 5 years, Operating Expenses stood at $38.8 million in 2022, then surged by 105.9% to $80.0 million in 2023, then dropped by 26.15% to $59.1 million in 2024, then tumbled by 30.73% to $40.9 million in 2025, then retreated by 17.04% to $33.9 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $33.9 million, $40.9 million, and $46.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 689.68 Mn | 610.55 Mn | - | 33.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.73 Mn |
| Mar 31, 2026 | 33.93 Mn |
| Dec 31, 2025 | 40.90 Mn |
| Sep 30, 2025 | 46.58 Mn |
| Jun 30, 2025 | 39.92 Mn |
| Mar 31, 2025 | 70.25 Mn |
| Dec 31, 2024 | 59.05 Mn |
| Sep 30, 2024 | 65.96 Mn |
| Jun 30, 2024 | 69.42 Mn |
| Mar 31, 2024 | 63.86 Mn |
| Dec 31, 2023 | 79.96 Mn |
| Sep 30, 2023 | 73.72 Mn |
| Jun 30, 2023 | 1.19 Bn |
| Mar 31, 2023 | 43.96 Mn |
| Dec 31, 2022 | 38.84 Mn |
| Sep 30, 2022 | 40.16 Mn |
| Jun 30, 2022 | 41.58 Mn |
| Mar 31, 2022 | 39.68 Mn |
| Dec 31, 2021 | 60.54 Mn |
| Sep 30, 2021 | 38.58 Mn |